919 results on '"Maraninchi, D."'
Search Results
2. Feasibility of High Dose Melphalan (140 mg/m2) and Peripheral Blood Stem Cell Support as Consolidation for Patients over 60 Years with Acute Myeloid Leukemia in First Complete Remission
3. Early Allogeneic Transplantation Favorably Influences the Outcome of Adult Patients Suffering from Acute Myeloid Leukemia
4. Phase I–II Study of Carboplatin with VP16 and Aracytin for Poor-Risk-Acute Leukemia
5. IL2 in Acute Leukemia
6. Phase I-II trial of Seraspenide (AcSDKP): a supressor of myelopoiesis protects against chemotherapy myelotoxicity (version 10 february 1993)
7. Prospective Study Comparing Idarubicin and Daunorubicin in Elderly Patients with Acute Myeloid Leukemia
8. Use of Recombinant Interleukin-2 (RU 49637) After Autologous Bone Marrow Transplantation in Patients with Hematological Disease: Phase I–II Study
9. Treatment of Relapsed Acute Leukemias with Systemic Recombinant Interleukin 2 (RU 49637)
10. Tolerance and Biological Activity of Bolus Administration of Increasing Doses of Glycosylated Recombinant Interleukin-2 (SR 29009) in Patients with Hematological Malignancy
11. Comparison of Chemotherapy and Autologous and Allogeneic Transplantation as Postinduction Regimen in Adult Acute Lymphoblastic Leukemia: a Preliminary Multicentric Study
12. Interleukin-2 (IL-2) After Autologous Bone Marrow Transplantation (BMT):A Pilot Study of Late Administration, 2–3 Months Post ABMT
13. Sequential Bolus Administration of rIL-2 (RU 49637) in Treatment of Advanced Solid Malignancies
14. Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs
15. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma
16. Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
17. Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation
18. Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
19. Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment
20. Les mesures de la qualité de vie en cancérologie peuvent-elles hanger la pratique des cliniciens?
21. Les banques de tissus tumoraux appliquées au cancer du sein : pourquoi? Comment?
22. Traitement précoce de l’anémie, en cours de chimiothérapie, par érythropoïétine : qu’attendre d’un schéma simplifié? À propos de l’expérience de l’Institut Paoli Calmettes-Marseille
23. Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution
24. Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy
25. Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
26. Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation
27. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study
28. Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis
29. Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens
30. Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation
31. Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles
32. Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
33. Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report
34. Protocolisation, utilisation et développement des médicaments anticancéreux dans le cadre de la mise en place de la T2A
35. Protocolisation, Use and Development of Anti-Cancer Drugs in the Context of T2A (Case-Mix Based Payment System) Set-Up
36. Autologous peripheral blood stem cell transplantation (PBSCT) in acute myeloid leukaemia (AML) in first complete remission (CR) a report of the BGMT cooperative group about 32 patients
37. High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation
38. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results
39. Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center
40. Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high–intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin’s lymphoma: an oligocentric report on 42 patients
41. Association of angiogenesis and poor prognosis in node‐positive patients receiving anthracycline‐based adjuvant chemotherapy
42. The role of autologous hematopoietic progenitor and cell reinfusion for intensive chemotherapy in women with poor-prognosis breast cancer. Clinical studies with ex-vivo expanded cells produced with the Aastrom Replicell® technology
43. Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involment
44. Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study
45. High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome
46. Altérations moléculaires des cancers du sein : applications cliniques et nouveaux outils d'analyse
47. High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
48. Detection of CBFβ/MYH11 fusion transcripts in acute myeloid leukemia: heterogeneity of cytological and molecular characteristics
49. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia
50. A RANDOMIZED PHASE III STUDY OF THALIDOMIDE VERSUS PLACEBO IN EXTENDED-DISEASE (ED) SMALL CELL LUNG CANCER (SCLC) PATIENTS AFTER RESPONSE TO CHEMOTHERAPY (CT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.